Basic Information
| LncRNA/CircRNA Name | DARS-AS1 |
| Synonyms | NA |
| Region | GRCh38_2:135985176-136022593 |
| Ensemble | ENSG00000231890 |
| Refseq | NR_110199 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR, Luciferase reporter assay, RIP |
| Sample | ovarian cancer tissue,cancer cell lines (A2780, SKOV3 and OVCAR-3), and normal ovarian cell (ISOE80) |
| Expression Pattern | up-regulated |
| Function Description | As a result, DARS-AS1 was significantly upregulated in tumor tissue samples |
| Pubmed ID | 30964159 |
| Year | 2019 |
| Title | Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer. |
External Links
| Links for DARS-AS1 | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |